Sens. Young, Hyde-Smith, Colleagues Call for FDA to Immediately Restore Oversight of Chemical Abortion Pills
February 26, 2022
February 26, 2022
WASHINGTON, Feb. 26 -- Sen. Todd Young, R-Indiana, issued the following news release:
U.S. Senator Todd Young (R-Ind.) joined Senator Cindy Hyde-Smith (R-Miss.) and U.S. Congressman Bob Latta (R-Ohio), along with 124 bicameral colleagues, in sending a letter to the U.S. Food and Drug Administration (FDA) requesting that it immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.
U.S. Senator Todd Young (R-Ind.) joined Senator Cindy Hyde-Smith (R-Miss.) and U.S. Congressman Bob Latta (R-Ohio), along with 124 bicameral colleagues, in sending a letter to the U.S. Food and Drug Administration (FDA) requesting that it immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.